StockData
IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV) stock

IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.60−7.13 (-2.69%)

Close on Nov 17, 2026Market cap $42.45BP/E 31.3Yield –

Iqvia cash

Cash and short-term investments held at the end of each period.

Iqvia's cash was $2.42B at Sep 30, 2026. For fiscal 2025 it was $2.14B, up 16.2% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $2.14B in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.14B+16.2%
FY2024Dec 31, 2024$1.84B+23.2%
FY2023Dec 31, 2023$1.50B+14.3%
FY2022Dec 31, 2022$1.31B-11.4%
FY2021Dec 31, 2021$1.48B-22.3%
FY2020Dec 31, 2020$1.90B+111.6%
FY2019Dec 31, 2019$899.00M-4.2%
FY2018Dec 31, 2018$938.00M-6.7%
FY2017Dec 31, 2017$1.01B-18.8%
FY2016Dec 31, 2016$1.24B+26.7%
FY2015Dec 31, 2015$977.00M+12.7%
FY2014Dec 31, 2014$867.00M+11.6%
FY2013Dec 31, 2013$777.00M+36.9%
FY2012Dec 31, 2012$567.73M+10.0%
FY2011Dec 31, 2011$516.30M-20.2%
FY2010Dec 31, 2010$646.62M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.42B+22.8%
Q2 FY2026Jun 30, 2026$2.08B-4.9%
Q1 FY2026Mar 31, 2026$2.10B+12.1%
Q4 FY2025Dec 31, 2025$2.14B+16.2%
Q3 FY2025Sep 30, 2025$1.97B+15.2%
Q2 FY2025Jun 30, 2025$2.19B+30.4%
Q1 FY2025Mar 31, 2025$1.88B+19.1%
Q4 FY2024Dec 31, 2024$1.84B+23.2%
Q3 FY2024Sep 30, 2024$1.71B+28.5%
Q2 FY2024Jun 30, 2024$1.68B+12.5%
Q1 FY2024Mar 31, 2024$1.58B-1.4%
Q4 FY2023Dec 31, 2023$1.50B+14.3%
Q3 FY2023Sep 30, 2023$1.33B-2.1%
Q2 FY2023Jun 30, 2023$1.49B-1.7%
Q1 FY2023Mar 31, 2023$1.60B+7.0%
Q4 FY2022Dec 31, 2022$1.31B-11.4%
Q3 FY2022Sep 30, 2022$1.36B-13.5%
Q2 FY2022Jun 30, 2022$1.52B-20.6%
Q1 FY2022Mar 31, 2022$1.49B-37.8%
Q4 FY2021Dec 31, 2021$1.48B-22.3%
Q3 FY2021Sep 30, 2021$1.57B+2.0%
Q2 FY2021Jun 30, 2021$1.91B+61.7%
Q1 FY2021Mar 31, 2021$2.40B+142.6%
Q4 FY2020Dec 31, 2020$1.90B+111.6%
Q3 FY2020Sep 30, 2020$1.54B+67.7%
Q2 FY2020Jun 30, 2020$1.18B+18.9%
Q1 FY2020Mar 31, 2020$990.00M-0.1%
Q4 FY2019Dec 31, 2019$899.00M-4.2%
Q3 FY2019Sep 30, 2019$920.00M+4.7%
Q2 FY2019Jun 30, 2019$994.00M+7.1%
Q1 FY2019Mar 31, 2019$991.00M-1.6%
Q4 FY2018Dec 31, 2018$938.00M-6.7%
Q3 FY2018Sep 30, 2018$879.00M-23.4%
Q2 FY2018Jun 30, 2018$928.00M-1.8%
Q1 FY2018Mar 31, 2018$1.01B+11.3%
Q4 FY2017Dec 31, 2017$1.01B-18.8%
Q3 FY2017Sep 30, 2017$1.15B–
Q2 FY2017Jun 30, 2017$945.00M–
Q1 FY2017Mar 31, 2017$905.00M–
Q4 FY2016Dec 31, 2016$1.24B–

More Iqvia figures

See a number that looks wrong?